Search company, investor...

Founded Year

1992

Stage

Acquired | Acquired

About JCE Biotechnology

Provider of protective equipment for controlled atmosphere environments. The company provides equipment including walled isolation suites, pressure isolators, transfer airlocks, sterilizers, laminar flow hoods, clean air devices, and protective suits. The company's products have applications in healthcare, the pharmaceutical industry, the food and beverage industries, and high-tech industries.

Headquarters Location

JCE Biotechnologie 3 avenue de Saint-Yorre

Hauterive, 03270,

France

33 4 70 59 51 40

Loading...

Loading...

JCE Biotechnology Patents

JCE Biotechnology has filed 2 patents.

The 3 most popular patent topics include:

  • antivirals
  • engine technology
  • experimental drugs
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/22/2021

2/13/2024

Engine technology, Lens mounts, Oil tankers, Mechanical engineering, Structural engineering

Grant

Application Date

11/22/2021

Grant Date

2/13/2024

Title

Related Topics

Engine technology, Lens mounts, Oil tankers, Mechanical engineering, Structural engineering

Status

Grant

Latest JCE Biotechnology News

Global Bio Decontamination Market Report to 2028: Featuring Ecolab, ClorDiSys Solutions, JCE Biotechnology and Howorth Air Technology Among Others

Mar 14, 2023

Global bio decontamination market is expected to observe impressive growth rate during the forecast period 2024-2028. The factors which are bolstering the growth of the market are rising prevalence of infectious as well as chronic diseases, growing elderly population, and the development in the pharmaceutical and biotechnology sectors. The rise in number of surgical procedures across the globe is also leading to increasing requirement for decontamination of surgical instruments. This factor is further creating profitable opportunities for bio decontamination market. Moreover, outsourcing bio decontamination services, coupled with extensive technological advancement are expected to impel the growth of the market. Additionally, growing development in pharmaceutical and biotechnology industries is fostering the growth of global bio decontamination market. The increasing availability of sophisticated biocontamination devices which require minimum manual intervention and are efficient are further anticipated to fuel the market growth through 2028. Global bio decontamination market is segmented based on product, type, agent type, end user and region. Based on end user, the market can be segmented into hospitals & clinics, ambulatory centers, bio-pharma companies, and others. Among these, the hospitals & clinics segment is expected to contribute high revenue during the forecast period owing to increasing usage of bio decontamination products to avoid HAIs and maintaining clean and disease-free environment. Regionally, North America is expected to dominate the global bio decontamination market in terms of revenue during the forecast period, which can be attributed to strict laws pertaining to medical safety in countries such as United States and Canada. In addition, Asia-Pacific is expected to witness steady growth through 2028. This is attributed to increasing government initiatives in countries such as India, China, among others for improving healthcare infrastructure. Market players operating in global bio decontamination market include Ecolab, Inc., ClorDiSys Solutions, Inc., JCE Biotechnology, Howorth Air Technology Limited, PMT (USA) LLC, Zhejiang Tailin Bioengineering Co., Ltd., Fedegari Autoclavi SpA, TOMI Environmental Solutions Inc., Amira Srl, and STERIS Life Science PLC. The companies are focusing on launching new products to enhance their product portfolios. Other growth strategies include mergers & acquisitions and partnerships. Report Scope: In this report, global bio decontamination market has been segmented into following categories, in addition to the industry trends which have also been detailed below: Global Bio Decontamination Market, By Product: Equipment Chamber Decontamination Hydrogen Peroxide Hospitals North America

JCE Biotechnology Frequently Asked Questions (FAQ)

  • When was JCE Biotechnology founded?

    JCE Biotechnology was founded in 1992.

  • Where is JCE Biotechnology's headquarters?

    JCE Biotechnology's headquarters is located at JCE Biotechnologie, Hauterive.

  • What is JCE Biotechnology's latest funding round?

    JCE Biotechnology's latest funding round is Acquired.

  • Who are the investors of JCE Biotechnology?

    Investors of JCE Biotechnology include Sofimac Partners.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.